Study guide

18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

Key Takeaways Explain This Topic AI

The simplified Bernoulli equation ΔP = 4V² converts velocity in m/s to an instantaneous gradient in mmHg; use 4(V₂² − V₁²) when proximal velocity is not negligible.

Stroke volume is cross-sectional area times VTI: with diameter in cm and VTI in cm, the result is cm³, numerically equal to mL; cardiac output multiplies by heart rate and converts mL/min to L/min.

Continuity calculations require conservation of flow, correctly paired sites and beats, and squared diameter measurements; a 5% diameter error produces about a 10% area and flow error.

Qp/Qs compares pulmonary with systemic stroke volume and requires valid RVOT and LVOT areas/VTIs plus explicit consideration of regurgitation, shunt location, rhythm, and alternative flow pathways.

Last updated: July 2026

Treat equations as models with units

CCI task D14 is to evaluate cardiac hemodynamics. Every calculation starts with a verified anatomic site, a clean Doppler envelope, correct units, and a stated assumption. Color locates acceleration, PW samples a discrete level, and CW records the highest velocity along the entire beam. Align as parallel as possible because measured velocity equals true velocity × cos θ; angle error underestimates velocity, and squaring magnifies the gradient error. Average appropriate beats and use matched cycles in irregular rhythm.

  • Quantity Equation Input units → output
  • Instantaneous gradient ΔP = 4V² m/s → mmHg
  • Full Bernoulli form ΔP = 4(V₂² − V₁²) m/s → mmHg
  • Circular area CSA = π(D/2)² = 0.785D² cm → cm²
  • Stroke volume SV = CSA × VTI cm² × cm = cm³ = mL/beat
  • Cardiac output CO = SV × HR / 1000 mL/beat × beats/min → L/min
  • Cardiac index CI = CO / BSA L/min ÷ m² → L/min/m²
  • Continuity valve area Area₂ = CSA₁ × VTI₁ / VTI₂ cm² × cm / cm → cm²
  • Shunt ratio Qp/Qs = SV pulmonary / SV systemic mL/mL → unitless
  • Apply Bernoulli to the right question

The simplified Bernoulli equation ΔP = 4V² estimates the peak instantaneous pressure difference across a high-velocity jet. At 4.0 m/s, ΔP is 4 × 16 = 64 mmHg . It is not the same as a catheter peak-to-peak gradient. A Doppler mean gradient is calculated by tracing the velocity envelope so the system integrates instantaneous gradients over ejection; it is not 4 times the square of the mean velocity.

The simplified form neglects proximal velocity. That is usually reasonable when V₁ is below about 1.5 m/s and much smaller than V₂. If V₁ is important, use 4(V₂² − V₁²) . With V₂ = 4.0 and V₁ = 1.5 m/s, the corrected gradient is 4(16 − 2.25) = 55 mmHg , not 64 mmHg. Serial obstructions, long tunnels, pressure recovery, poor alignment, high-output states, and very low flow weaken simple interpretations. For MR, TR, VSD, or aortic coarctation, confirm the jet identity and the relevant upstream pressure assumptions before converting velocity to chamber pressure.

Build stroke volume and continuity from one flow cylinder

For laminar flow through a circular site, SV = CSA × VTI . Measure diameter perpendicular to flow at the prescribed anatomic level, square it to obtain area, and place PW at the corresponding flow site without spectral broadening or acceleration. With LVOT diameter 2.0 cm and LVOT VTI 20 cm, CSA = 0.785 × 2.0² = 3.14 cm² and SV = 3.14 × 20 = 62.8 mL/beat . At 75 beats/min, CO = 62.8 × 75 / 1000 = 4.71 L/min . If BSA is 1.8 m², CI = 4.71/1.8 = 2.62 L/min/m² .

Diameter is the dominant error because it is squared. A 5% diameter overmeasurement produces 1.05² = 1.1025, about a 10% area and SV overestimate , before VTI error is added. An oval or off-axis outflow tract, calcified border, wrong phase, sample too close to the valve, and mismatched ectopic beats can therefore produce a precise-looking but inaccurate output. VTI tracing should follow the dense modal velocity, not faint noise. Average multiple beats when rhythm or respiration varies.

Continuity assumes that the same volume crosses two sites during the same time interval with no intervening shunt or important regurgitant loss. For aortic stenosis, AVA = CSA LVOT × VTI LVOT / VTI AV . Using the example above and an aortic VTI of 80 cm gives AVA = 3.14 × 20 / 80 = 0.785 cm² . The dimensionless index, VTI LVOT/VTI AV = 0.25, removes the LVOT diameter but does not remove sampling or alignment errors. In subaortic obstruction, significant AR, irregular rhythm, or discordant low-flow states, document assumptions and integrate morphology, gradients, SV index, EF, and other evidence.

Quantify shunts without hiding the weak link

For one intracardiac left-to-right shunt with no important semilunar regurgitation, Qp/Qs = (CSA RVOT × VTI RVOT) / (CSA LVOT × VTI LVOT) . A ratio above 1 indicates pulmonary flow exceeds systemic flow; below 1 suggests net right-to-left flow or a measurement/problem configuration that must be reconciled. The ratio is unitless because mL/beat divides by mL/beat. Report which pulmonary and systemic sites were used.

Measure RVOT and LVOT diameters and PW VTIs at their matched sites using the same rhythm and comparable beats. Because two squared diameters enter the ratio, small independent errors can produce a large false shunt. Pulmonary or aortic regurgitation, multiple shunts, PDA location, anomalous venous return, cavopulmonary connections, mechanical support, and changing loading violate the simple model. Color and agitated saline define direction or pathway but do not replace quantitative flow when Qp/Qs is needed. Conversely, a calculated ratio must agree with chamber remodeling and defect anatomy. If it does not, remeasure before reporting; use CMR or invasive oximetry when echo remains unreliable.

Regurgitant calculations use the same conservation principle: regurgitant volume equals total SV across the regurgitant valve minus forward SV at a nonregurgitant reference site, in mL/beat; regurgitant fraction is regurgitant volume divided by total SV × 100%. Different annular shapes, rhythm, and more than one regurgitant lesion magnify error. Hemodynamic calculations support severity only after image quality, assumptions, and units survive this audit.